o:2716 A Journey Into the Unknown: PhD Students in a European Training Network on Age-related Changes in Hematopoiesis Conduct Their Project During a Global Pandemic en The age-related changes in hematopoiesis (ARCH) project is part of the Innovative Training Network (ITN) of the Marie-Sklodowska Curie Actions (MSCA) program, which provides doctorate training of excellence based on the exchange of ideas and competencies from the academic and private sectors.1 The ARCH project intends to outline hematopoietic stem cell (HSC) alterations with aging, how hematopoietic cell individuality is controlled at the transcriptional and epigenetic levels in normal hematopoiesis and in leukemias, and understand the crosstalk between intrinsic and extrinsic indications that support the proliferation of preleukemic and leukemic cells within the hematopoietic niche. We are 15 PhD students funded by this network, based around Europe, and our common aim is to understand functional changes in the hematopoietic system with age, how these changes link to the development of age-associated diseases and in parallel work towards the development of new treatments.2 Our projects kicked off just when the severe acute respiratory coronavirus-2 (SARS-CoV-2) emerged. Two and a half years later, SARS-CoV-2 continues to infect millions of people and has taken the lives of at least 6 million people worldwide.3 The COVID-19 outbreak brought along social isolation and feelings of uncertainty to everyone around the world, including doctorate students.4,5 Ironically, our projects have been more relevant than ever, as the pandemic has highlighted the important relationship between age-related changes in hematopoiesis and disease severity. Below, we aim to discuss the timeline of the ARCH project throughout the pandemic and how we managed to courageously pull through the hardships of doing research during a global pandemic within different settings (academia/institutes and industry). We provide recommendations to future PhD students on how to manage their PhD projects during global emergencies. financial management; hematopoiesis; hematopoietic cell; human; leukemia cell; medical education; pandemic; PhD student; private sector; psychological well-being; Review; scientific literature; Severe acute respiratory syndrome coronavirus 2 1552099 10.1097/HS9.0000000000000763 2024-03-13T09:04:48.717Z 44 yes 46 Christina Pitsillidou Università degli Studi Milano-Bicocca / FlowMetric Europe Sandra Alonso-Rubido Università degli Studi Milano-Bicocca / Diagenode SA person Andrea Ávila-Ávila Institute Curie person Mari Carmen Romero-Mulero Max Planck Institute of Immunobiology and Epigenetics person Agata Labedz Università degli Studi Milano-Bicocca person Athanasios Oikonomou Centro Maria Letizia Verga / Università degli Studi Milano-Bicocca person Ludovica Proietti University of Veterinary Medicine Vienna person Maria Eleni Psychoyiou King's College London person Clara Tellez-Quijorna Centre de Recherche en Cancèrologie de Marseille person Maniriho Hillary Tel Aviv University person Eirini Sofia Fasouli Università degli Studi Milano-Bicocca / Academy of Athens person Guillermo Fernández-Rodríguez Sapienza University of Rome person Natalia Giner-Laguarda Centro de Investigaciones Biológicas Margarita Salas person Natalia Skinder University of Groningen person Chiara Taroni Université de Strasbourg person John Strouboulis King's College London person Eleni Katsantoni Academy of Athens person Antonella Ellena Ronchi Università degli Studi Milano-Bicocca person application/pdf 1005555 https://phaidra.vetmeduni.ac.at/o:2716 no yes 16 70 1552253 HemaSphere 3 6 8 Lippincott Williams & Wilkins 2022